Having trouble accessing articles? Reset your cache.

EPS watch

EPS watch

EPS watch
PDL (PDLI) and ViroPharma (VPHM) both had big declines after reporting first quarter numbers that were worse than expected. On the upside, Myriad (MYGN) jumped 11% after posting strong sales growth for its predictive medicine products. (A) Results for 2Q ended March 31; (B) Results for 3Q ended March 31; Mcap in $M
Company 1Q06 EPS est 1Q06 EPS actual Outcome Growth from 1Q05 5/5 cls Wk chg % chg Mcap chg 5/5

Read the full 771 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE